{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:28:23Z","timestamp":1785353303188,"version":"3.55.0"},"reference-count":221,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Neurodegenerative diseases, such as Parkinson\u2019s and Alzheimer\u2019s, are becoming an increasingly serious challenge for modern medicine because of the significant increase in incidence and the narrow range of effective therapeutic strategies. In recent years, the kynurenine pathway, which is one of the main pathways of tryptophan metabolism, responsible for the synthesis of products that act oppositely in the CNS including neurotoxic (quinolinic acid) and neuroprotective products, has gained increasing recognition as a potential therapeutic target. Abnormalities in the production of these metabolites, causing a disruption of homeostasis in the CNS, often lead to the development of inflammation, which can cause oxidative stress or neuronal death. This paper aims to discuss strategies useful in modulation of the kynurenine pathway, based on increasing the production of neuroprotective metabolites and reducing the synthesis of neurotoxic compounds, as well as to outline the progress in preclinical and clinical studies and the challenges encountered in these studies, among others, in the search for new KP inhibitors. The pharmacological (IDO and KMO inhibitors) and non-pharmacological (physical activity, diet) strategies are discussed, as well as new approaches from combination and targeted therapies. Together with the results of preclinical studies, they demonstrate the high utility of this target in the treatment of neurodegeneration. Despite its promising activity, further key studies are needed to fully understand the mechanisms involved in metabolism, which may translate into increased efficacy of developed therapies in the future.<\/jats:p>","DOI":"10.3390\/life16020266","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T09:02:01Z","timestamp":1770195721000},"page":"266","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Modulation of the Kynurenine Pathway: A New Approach for Treating Neurodegeneration"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2351-5321","authenticated-orcid":false,"given":"Julia K.","family":"Banaszkiewicz","sequence":"first","affiliation":[{"name":"Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 8b Street, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kukie\u0142ka","sequence":"additional","affiliation":[{"name":"Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 8b Street, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Kudyk","sequence":"additional","affiliation":[{"name":"Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 8b Street, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ucja J.","family":"Walczak","sequence":"additional","affiliation":[{"name":"Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 8b Street, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9945-7446","authenticated-orcid":false,"given":"Katarzyna","family":"Wicha-Komsta","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, Faculty of Medicine, The John Paul II Catholic University of Lublin, Konstantyn\u00f3w 1H Street, 20-708 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariola","family":"Herbet","sequence":"additional","affiliation":[{"name":"Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 8b Street, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Pi\u0105tkowska-Chmiel","sequence":"additional","affiliation":[{"name":"Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 8b Street, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0503-8847","authenticated-orcid":false,"given":"Grzegorz","family":"Nowicki","sequence":"additional","affiliation":[{"name":"Department of Family and Geriatric Nursing, Faculty of Health Sciences, Medical University of Lublin, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen E.","family":"Mielnik","sequence":"additional","affiliation":[{"name":"County Health Center in Opole Lubelskie, Przemys\u0142owa 4a, 24-300 Opole Lubelskie, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7587-2626","authenticated-orcid":false,"given":"Tomasz","family":"Kocki","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, Faculty of Medicine, The John Paul II Catholic University of Lublin, Konstantyn\u00f3w 1H Street, 20-708 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Le Gall, L., Anakor, E., Connolly, O., Vijayakumar, U.G., Duddy, W.J., and Duguez, S. (2020). Molecular and Cellular Mechanisms Affected in ALS. J. Pers. Med., 10.","DOI":"10.3390\/jpm10030101"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lamptey, R.N.L., Chaulagain, B., Trivedi, R., Gothwal, A., Layek, B., and Singh, J. (2022). A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031851"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of Neuroinflammation in Neurodegeneration Development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in Neurodegenerative Disorders: The Roles of Microglia and Astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1111\/jnc.16015","article-title":"Tryptophan Metabolism as a \u2018Reflex\u2019 Feature of Neuroimmune Communication: Sensor and Effector Functions for the Indoleamine-2, 3-Dioxygenase Kynurenine Pathway","volume":"168","author":"Stone","year":"2024","journal-title":"J. Neurochem."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Muzio, L., Viotti, A., and Martino, G. (2021). Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy. Front. Neurosci., 15.","DOI":"10.3389\/fnins.2021.742065"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.it.2020.07.007","article-title":"The Role of Astrocytes in CNS Inflammation","volume":"41","author":"Giovannoni","year":"2020","journal-title":"Trends Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1038\/s41401-025-01576-w","article-title":"Molecular Mechanisms of Excitotoxicity and Their Relevance to the Pathogenesis of Neurodegenerative Diseases\u2014An Update","volume":"46","author":"Wu","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Li, Z., and Gong, C. (2025). NLRP3 Inflammasome in Alzheimer\u2019s Disease: Molecular Mechanisms and Emerging Therapies. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1583886"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-020-0145-7","article-title":"NLRP3 Inflammasome as a Novel Therapeutic Target for Alzheimer\u2019s Disease","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"8008","DOI":"10.1038\/s41598-018-25968-7","article-title":"Alterations in Serum Kynurenine Pathway Metabolites in Individuals with High Neocortical Amyloid-\u03b2 Load: A Pilot Study","volume":"8","author":"Chatterjee","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Pathak, S., Nadar, R., Kim, S., Liu, K., Govindarajulu, M., Cook, P., Watts Alexander, C.S., Dhanasekaran, M., and Moore, T. (2024). The Influence of Kynurenine Metabolites on Neurodegenerative Pathologies. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25020853"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mor, A., Tankiewicz-Kwedlo, A., Krupa, A., and Pawlak, D. (2021). Role of Kynurenine Pathway in Oxidative Stress during Neurodegenerative Disorders. Cells, 10.","DOI":"10.3390\/cells10071603"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e2400721","DOI":"10.1002\/ardp.202400721","article-title":"Natural Products against Tau Hyperphosphorylation-Induced Aggregates: Potential Therapies for Alzheimer\u2019s Disease","volume":"358","author":"Diaz","year":"2025","journal-title":"Arch. Pharm."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Abramov, A.Y., Potapova, E.V., Dremin, V.V., and Dunaev, A.V. (2020). Interaction of Oxidative Stress and Misfolded Proteins in the Mechanism of Neurodegeneration. Life, 10.","DOI":"10.3390\/life10070101"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ciechanover, A., and Kwon, Y.T. (2017). Protein Quality Control by Molecular Chaperones in Neurodegeneration. Front. Neurosci., 11.","DOI":"10.3389\/fnins.2017.00185"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"105783","DOI":"10.1016\/j.nbd.2022.105783","article-title":"Systemic Perturbations of the Kynurenine Pathway Precede Progression to Dementia Independently of Amyloid-\u03b2","volume":"171","author":"Cespedes","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Guo, S., Wang, H., and Yin, Y. (2022). Microglia Polarization From M1 to M2 in Neurodegenerative Diseases. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.815347"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ferreira, S.A., and Romero-Ramos, M. (2018). Microglia Response During Parkinson\u2019s Disease: Alpha-Synuclein Intervention. Front. Cell. Neurosci., 12.","DOI":"10.3389\/fncel.2018.00247"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","article-title":"Astrocytic and Microglial Cells as the Modulators of Neuroinflammation in Alzheimer\u2019s Disease","volume":"19","author":"Singh","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1111\/j.1582-4934.2008.00402.x","article-title":"Neuronal Cell Death in Neurodegenerative Diseases: Recurring Themes around Protein Handling","volume":"12","author":"Gorman","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI200317522","article-title":"Series Introduction: Neurodegeneration: What Is It and Where Are We?","volume":"111","author":"Przedborski","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_23","unstructured":"(2025, August 31). Alzheimer\u2019s Disease Fact Sheet, Available online: https:\/\/www.nia.nih.gov\/health\/alzheimers-and-dementia\/alzheimers-disease-fact-sheet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.trci.2019.05.008","article-title":"Alzheimer\u2019s Disease Drug Development Pipeline: 2019","volume":"5","author":"Cummings","year":"2019","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"107152","DOI":"10.1016\/j.bioorg.2024.107152","article-title":"A Comprehensive Review of Multi-Target Directed Ligands in the Treatment of Alzheimer\u2019s Disease","volume":"144","author":"Pathak","year":"2024","journal-title":"Bioorganic Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1570159X113116660047","article-title":"Multi-Target-Directed Ligands and Other Therapeutic Strategies in the Search of a Real Solution for Alzheimer\u2019s Disease","volume":"12","author":"Fernandez","year":"2014","journal-title":"Curr. Neuropharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Walczak-Nowicka, \u0141.J., and Herbet, M. (2021). Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in Their Pathogenesis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179290"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-Target-Directed Ligands To Combat Neurodegenerative Diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.3233\/JAD-179932","article-title":"Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology","volume":"64","author":"Hampel","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","article-title":"The Kynurenine Pathway: A Finger in Every Pie","volume":"25","author":"Savitz","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_31","first-page":"1003","article-title":"Neuroinflammation Induces Neurodegeneration","volume":"1","author":"Kempuraj","year":"2016","journal-title":"J. Neurol. Neurosurg. Spine"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Parrott, J.M., and O\u2019Connor, J.C. (2015). Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology. Front. Psychiatry, 6.","DOI":"10.3389\/fpsyt.2015.00116"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.abb.2004.09.031","article-title":"Role of Coactivators in Transcriptional Activation by the Aryl Hydrocarbon Receptor","volume":"433","author":"Hankinson","year":"2005","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"107845","DOI":"10.1016\/j.pharmthera.2021.107845","article-title":"Kynurenine Emerges from the Shadows\u2014Current Knowledge on Its Fate and Function","volume":"225","author":"Walczak","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1440-1711.2003.t01-1-01177.x","article-title":"Tryptophan and the Immune Response","volume":"81","author":"Moffett","year":"2003","journal-title":"Immunol. Cell Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/npp.2014.194","article-title":"Putative Neuroprotective and Neurotoxic Kynurenine Pathway Metabolites Are Associated with Hippocampal and Amygdalar Volumes in Subjects with Major Depressive Disorder","volume":"40","author":"Savitz","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"eaaf9794","DOI":"10.1126\/science.aaf9794","article-title":"Kynurenines: Tryptophan\u2019s Metabolites in Exercise, Inflammation, and Mental Health","volume":"357","author":"Cervenka","year":"2017","journal-title":"Science"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Campbell, B.M., Charych, E., Lee, A.W., and M\u00f6ller, T. (2014). Kynurenines in CNS Disease: Regulation by Inflammatory Cytokines. Front. Neurosci., 8.","DOI":"10.3389\/fnins.2014.00012"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2012.08.005","article-title":"The Kynurenine Pathway in Neurodegenerative Diseases: Mechanistic and Therapeutic Considerations","volume":"323","author":"Tan","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An Endogenous Tumour-Promoting Ligand of the Human Aryl Hydrocarbon Receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Bratek-Gerej, E., Ziembowicz, A., Godlewski, J., and Salinska, E. (2021). The Mechanism of the Neuroprotective Effect of Kynurenic Acid in the Experimental Model of Neonatal Hypoxia\u2013Ischemia: The Link to Oxidative Stress. Antioxidants, 10.","DOI":"10.3390\/antiox10111775"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Stone, T.W., Darlington, L.G., Badawy, A.A.-B., and Williams, R.O. (2024). The Complex World of Kynurenic Acid: Reflections on Biological Issues and Therapeutic Strategy. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25169040"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Lajk\u00f3, N., Kata, D., Szab\u00f3, M., M\u00e1ty\u00e1s, A., Dulka, K., F\u00f6ldesi, I., F\u00fcl\u00f6p, F., Gulya, K., V\u00e9csei, L., and Mih\u00e1ly, A. (2020). Sensitivity of Rodent Microglia to Kynurenines in Models of Epilepsy and Inflammation In Vivo and In Vitro: Microglia Activation Is Inhibited by Kynurenic Acid and the Synthetic Analogue SZR104. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239333"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: Recent Advances and New Questions","volume":"12","author":"Toldi","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2009.02.326","article-title":"The Role of Kynurenines in Disorders of the Central Nervous System: Possibilities for Neuroprotection","volume":"283","author":"Vamos","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"ref_46","first-page":"359","article-title":"The E3 Ubiquitin Ligase, HECTD1, Is Involved in ABCA1-Mediated Cholesterol Export from Macrophages","volume":"1863","author":"Aleidi","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","article-title":"3-Hydroxykynurenine, an Endogenous Oxidative Stress Generator, Causes Neuronal Cell Death with Apoptotic Features and Region Selectivity","volume":"70","author":"Okuda","year":"1998","journal-title":"J. Neurochem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.freeradbiomed.2014.11.013","article-title":"The Basics of Thiols and Cysteines in Redox Biology and Chemistry","volume":"80","author":"Poole","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neuropharm.2016.01.011","article-title":"L-Tryptophan-Kynurenine Pathway Enzymes Are Therapeutic Target for Neuropsychiatric Diseases: Focus on Cell Type Differences","volume":"112","author":"Fujigaki","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2011.05.031","article-title":"Treating the Periphery to Ameliorate Neurodegenerative Diseases","volume":"145","author":"Reinhart","year":"2011","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbi.2024.11.031","article-title":"Central and Peripheral Kynurenine Pathway Metabolites in COVID-19: Implications for Neurological and Immunological Responses","volume":"124","author":"Li","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bbi.2019.06.033","article-title":"Microglial Production of Quinolinic Acid as a Target and a Biomarker of the Antidepressant Effect of Ketamine","volume":"81","author":"Verdonk","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.semcdb.2015.03.002","article-title":"The Kynurenine Pathway and Neurodegenerative Disease","volume":"40","author":"Maddison","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","article-title":"Tryptophan Metabolism in Health and Disease","volume":"35","author":"Xue","year":"2023","journal-title":"Cell Metab."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0031-6997(25)00441-7","article-title":"Neuropharmacology of Quinolinic and Kynurenic Acids","volume":"45","author":"Stone","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Phillips, R.S., Iradukunda, E.C., Hughes, T., and Bowen, J.P. (2019). Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition. Front. Mol. Biosci., 6.","DOI":"10.3389\/fmolb.2019.00003"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Hughes, T.D., G\u00fcner, O.F., Iradukunda, E.C., Phillips, R.S., and Bowen, J.P. (2022). The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors. Molecules, 27.","DOI":"10.3390\/molecules27010273"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Klaessens, S., Stroobant, V., De Plaen, E., and Van den Eynde, B.J. (2022). Systemic Tryptophan Homeostasis. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.897929"},{"key":"ref_59","first-page":"e12525","article-title":"Vitamin B6 and Vitamin D Deficiency Co-Occurrence in Geriatric Memory Patients","volume":"16","author":"Przybelski","year":"2024","journal-title":"Alzheimer\u2019s Dement. Diagn. Assess. Dis. Monit."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"100226","DOI":"10.1016\/j.ahr.2025.100226","article-title":"Unraveling the Molecular Mechanisms of Vitamin Deficiency in Alzheimer\u2019s Disease Pathophysiology","volume":"5","author":"Sharma","year":"2025","journal-title":"Aging Health Res."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Rai, S.N., Singh, P., Steinbusch, H.W.M., Vamanu, E., Ashraf, G., and Singh, M.P. (2021). The Role of Vitamins in Neurodegenerative Disease: An Update. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101284"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.3390\/nu7095333","article-title":"Associations between B Vitamins and Parkinson\u2019s Disease","volume":"7","author":"Shen","year":"2015","journal-title":"Nutrients"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41531-025-00964-7","article-title":"Parkinson\u2019s Disease Is Characterized by Vitamin B6-Dependent Inflammatory Kynurenine Pathway Dysfunction","volume":"11","author":"Wilson","year":"2025","journal-title":"NPJ Park. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Shah, H., Dehghani, F., Ramezan, M., Gannaban, R.B., Haque, Z.F., Rahimi, F., Abbasi, S., and Shin, A.C. (2023). Revisiting the Role of Vitamins and Minerals in Alzheimer\u2019s Disease. Antioxidants, 12.","DOI":"10.3390\/antiox12020415"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mam.2016.08.001","article-title":"Inflammation, Vitamin B6 and Related Pathways","volume":"53","author":"Ueland","year":"2017","journal-title":"Mol. Asp. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3945\/jn.110.133082","article-title":"Low Plasma Vitamin B-6 Status Affects Metabolism through the Kynurenine Pathway in Cardiovascular Patients with Systemic Inflammation1\u20134","volume":"141","author":"Midttun","year":"2011","journal-title":"J. Nutr."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jn\/107.2.261","article-title":"Effects of Vitamin B-6 Deficiency and Tryptophan Loading on Urinary Excretion of Tryptophan Metabolites in Mammals","volume":"107","author":"Yeh","year":"1977","journal-title":"J. Nutr."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/jn\/nxy268","article-title":"Lower Plasma Vitamin B-6 Is Associated with 2-Year Cognitive Decline in the Boston Puerto Rican Health Study","volume":"149","author":"Palacios","year":"2019","journal-title":"J. Nutr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3945\/ajcn.117.157834","article-title":"Intake of Niacin, Folate, Vitamin B-6, and Vitamin B-12 through Young Adulthood and Cognitive Function in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study","volume":"106","author":"Qin","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1079\/BJN19900089","article-title":"Tryptophan Metabolism in Vitamin B6-Deficient Mice","volume":"63","author":"Bender","year":"1990","journal-title":"Br. J. Nutr."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1017\/S0007114514001858","article-title":"Vitamins B2 and B6 as Determinants of Kynurenines and Related Markers of Interferon-\u03b3-Mediated Immune Activation in the Community-Based Hordaland Health Study","volume":"112","author":"Theofylaktopoulou","year":"2014","journal-title":"Br. J. Nutr."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Gan, Y., Chen, Y., Zhong, H., Liu, Z., Geng, J., Wang, H., and Wang, W. (2024). Gut Microbes in Central Nervous System Development and Related Disorders. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1288256"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-024-01743-1","article-title":"Microbiota\u2013Gut\u2013Brain Axis and Its Therapeutic Applications in Neurodegenerative Diseases","volume":"9","author":"Loh","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Scott, G.A., Terstege, D.J., Vu, A.P., Law, S., Evans, A., and Epp, J.R. (2020). Disrupted Neurogenesis in Germ-Free Mice: Effects of Age and Sex. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00407"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbi.2016.02.020","article-title":"Cognitive Impairment by Antibiotic-Induced Gut Dysbiosis: Analysis of Gut Microbiota-Brain Communication","volume":"56","author":"Farzi","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Schwarcz, R., Foo, A., Sathyasaikumar, K.V., and Notarangelo, F.M. (2024). The Probiotic Lactobacillus Reuteri Preferentially Synthesizes Kynurenic Acid from Kynurenine. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25073679"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuropharm.2016.07.002","article-title":"Kynurenine Pathway Metabolism and the Microbiota-Gut-Brain Axis","volume":"112","author":"Kennedy","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e00332-23","DOI":"10.1128\/msystems.00332-23","article-title":"Metabolic Network Construction Reveals Probiotic-Specific Alterations in the Metabolic Activity of a Synthetic Small Intestinal Community","volume":"8","author":"Jansma","year":"2023","journal-title":"mSystems"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2020.12.026","article-title":"Prebiotic and Probiotic Supplementation and the Tryptophan-Kynurenine Pathway: A Systematic Review and Meta Analysis","volume":"123","author":"Purton","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s10753-024-02135-x","article-title":"The Kynurenine Pathway in Gut Permeability and Inflammation","volume":"48","author":"Kearns","year":"2025","journal-title":"Inflammation"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Aktas, B., De Wolfe, T.J., Safdar, N., Darien, B.J., and Steele, J.L. (2016). The Impact of Lactobacillus Casei on the Composition of the Cecal Microbiota and Innate Immune System Is Strain Specific. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0156374"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Kong, Q., Chen, Q., Mao, X., Wang, G., Zhao, J., Zhang, H., and Chen, W. (2022). Bifidobacterium Longum CCFM1077 Ameliorated Neurotransmitter Disorder and Neuroinflammation Closely Linked to Regulation in the Kynurenine Pathway of Autistic-like Rats. Nutrients, 14.","DOI":"10.3390\/nu14081615"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"139503","DOI":"10.1016\/j.ijbiomac.2025.139503","article-title":"Inulin Alleviates Chronic Ketamine-Induced Impairments in Memory and Prepulse Inhibition by Regulating the Gut Microbiota, Inflammation, and Kynurenine Pathway","volume":"294","author":"Xu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"105911","DOI":"10.1016\/j.ibiod.2024.105911","article-title":"Quinolinic Acid Degradation Mediated by a Unique Qut Cluster in Pigmentiphaga Sp. YJ18","volume":"195","author":"Wang","year":"2024","journal-title":"Int. Biodeterior. Biodegrad."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Moln\u00e1r, K., L\u0151rinczi, B., Fazakas, C., Szatm\u00e1ri, I., F\u00fcl\u00f6p, F., Kmetyk\u00f3, N., Berkecz, R., Ilisz, I., Krizbai, I.A., and Wilhelm, I. (2021). SZR-104, a Novel Kynurenic Acid Analogue with High Permeability through the Blood-Brain Barrier. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13010061"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0014-2999(00)00024-8","article-title":"Systemic Administration of 4-Chlorokynurenine Prevents Quinolinate Neurotoxicity in the Rat Hippocampus","volume":"390","author":"Wu","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Bourque, M., Gr\u00e9goire, L., Patel, W., Dickens, D., Snodgrass, R., and Di Paolo, T. (2022). AV-101, a Pro-Drug Antagonist at the NMDA Receptor Glycine Site, Reduces L-Dopa Induced Dyskinesias in MPTP Monkeys. Cells, 11.","DOI":"10.3390\/cells11223530"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0006-8993(00)01962-4","article-title":"Systemically Administered D-Glucose Conjugates of 7-Chlorokynurenic Acid Are Centrally Available and Exert Anticonvulsant Activity in Rodents","volume":"860","author":"Battaglia","year":"2000","journal-title":"Brain Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"101","DOI":"10.55782\/ane-2003-1459","article-title":"FK506 Attenuates 1-Methyl-4-Phenylpyridinium- and 3-Nitropropionic Acid-Evoked Inhibition of Kynurenic Acid Synthesis in Rat Cortical Slices","volume":"63","author":"Luchowska","year":"2003","journal-title":"Acta Neurobiol. Exp."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2225800","DOI":"10.1080\/14756366.2023.2225800","article-title":"Research Progress on the Kynurenine Pathway in the Prevention and Treatment of Parkinson\u2019s Disease","volume":"38","author":"Chen","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s10194-016-0654-5","article-title":"KYNA Analogue SZR72 Modifies CFA-Induced Dural Inflammation- Regarding Expression of pERK1\/2 and IL-1\u03b2 in the Rat Trigeminal Ganglion","volume":"17","author":"Warfvinge","year":"2016","journal-title":"J. Headache Pain"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"113257","DOI":"10.1016\/j.biopha.2022.113257","article-title":"Analog of Kynurenic Acid Decreases Tau Pathology by Modulating Astrogliosis in Rat Model for Tauopathy","volume":"152","author":"Majerova","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"108379","DOI":"10.1016\/j.clim.2020.108379","article-title":"Role of Diet in Regulating the Gut Microbiota and Multiple Sclerosis","volume":"235","author":"Sanchez","year":"2022","journal-title":"Clin. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/cei\/uxad138","article-title":"Effect of the Ketone Beta-Hydroxybutyrate on Markers of Inflammation and Immune Function in Adults with Type 2 Diabetes","volume":"216","author":"Neudorf","year":"2024","journal-title":"Clin. Exp. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/s42003-023-05478-7","article-title":"A Ketogenic Diet Can Mitigate SARS-CoV-2 Induced Systemic Reprogramming and Inflammation","volume":"6","author":"Palermo","year":"2023","journal-title":"Commun. Biol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1194\/jlr.M079251","article-title":"Regulation of Kynurenine Metabolism by a Ketogenic Diet","volume":"59","author":"Heischmann","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/s41467-025-57414-4","article-title":"Disruption of Tryptophan Metabolism by High-Fat Diet-Triggered Maternal Immune Activation Promotes Social Behavioral Deficits in Male Mice","volume":"16","author":"Sun","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Kurowska, A., Ziemich\u00f3d, W., Herbet, M., and Pi\u0105tkowska-Chmiel, I. (2023). The Role of Diet as a Modulator of the Inflammatory Process in the Neurological Diseases. Nutrients, 15.","DOI":"10.3390\/nu15061436"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1093\/jn\/nxab231","article-title":"Inflammation-Related Marker Profiling of Dietary Patterns and All-Cause Mortality in the Melbourne Collaborative Cohort Study","volume":"151","author":"Li","year":"2021","journal-title":"J. Nutr."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1093\/ajcn\/nqab238","article-title":"Metabolomics of the Tryptophan-Kynurenine Degradation Pathway and Risk of Atrial Fibrillation and Heart Failure: Potential Modification Effect of Mediterranean Diet","volume":"114","author":"Razquin","year":"2021","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.pharep.2016.06.008","article-title":"Resveratrol Intake Enhances Indoleamine-2,3-Dioxygenase Activity in Humans","volume":"68","author":"Gualdoni","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Fukuwatari, T. (2020). Possibility of Amino Acid Treatment to Prevent the Psychiatric Disorders via Modulation of the Production of Tryptophan Metabolite Kynurenic Acid. Nutrients, 12.","DOI":"10.3390\/nu12051403"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s11064-016-1940-y","article-title":"Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain","volume":"41","author":"Sekine","year":"2016","journal-title":"Neurochem. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jnutbio.2018.05.002","article-title":"Fish Oil Ameliorates Sickness Behavior Induced by Lipopolysaccharide in Aged Mice through the Modulation of Kynurenine Pathway","volume":"58","author":"Souza","year":"2018","journal-title":"J. Nutr. Biochem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3988\/jcn.2015.11.3.212","article-title":"Protective Effects of Physical Exercise in Alzheimer\u2019s Disease and Parkinson\u2019s Disease: A Narrative Review","volume":"11","author":"Paillard","year":"2015","journal-title":"J. Clin. Neurol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2047-9158-3-5","article-title":"The Effects of Exercise on Cognition in Parkinson\u2019s Disease: A Systematic Review","volume":"3","author":"Murray","year":"2014","journal-title":"Transl. Neurodegener."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Kupjetz, M., Joisten, N., Rademacher, A., Gonzenbach, R., Bansi, J., and Zimmer, P. (2023). Cycling in Primary Progressive Multiple Sclerosis (CYPRO): Study Protocol for a Randomized Controlled Superiority Trial Evaluating the Effects of High-Intensity Interval Training in Persons with Primary Progressive Multiple Sclerosis. BMC Neurol., 23.","DOI":"10.1186\/s12883-023-03187-6"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cell.2014.07.051","article-title":"Skeletal Muscle PGC-1\u03b11 Modulates Kynurenine Metabolism and Mediates Resilience to Stress-Induced Depression","volume":"159","author":"Agudelo","year":"2014","journal-title":"Cell"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/s41467-019-10712-0","article-title":"Skeletal Muscle PGC-1\u03b11 Reroutes Kynurenine Metabolism to Increase Energy Efficiency and Fatigue-Resistance","volume":"10","author":"Agudelo","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"C836","DOI":"10.1152\/ajpcell.00053.2016","article-title":"Endurance Exercise Increases Skeletal Muscle Kynurenine Aminotransferases and Plasma Kynurenic Acid in Humans","volume":"310","author":"Schlittler","year":"2016","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Mudry, J.M., Alm, P.S., Erhardt, S., Goiny, M., Fritz, T., Caidahl, K., Zierath, J.R., Krook, A., and Wallberg-Henriksson, H. (2016). Direct Effects of Exercise on Kynurenine Metabolism in People with Normal Glucose Tolerance or Type 2 Diabetes, John Wiley and Sons.","DOI":"10.1002\/dmrr.2798"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.physbeh.2018.07.015","article-title":"Acute and Chronic Effects of Exercise on the Kynurenine Pathway in Humans\u2014A Brief Review and Future Perspectives","volume":"194","author":"Metcalfe","year":"2018","journal-title":"Physiol. Behav."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/s41598-021-81306-4","article-title":"Differential Effects on Blood and Cerebrospinal Fluid Immune Protein Markers and Kynurenine Pathway Metabolites from Aerobic Physical Exercise in Healthy Subjects","volume":"11","author":"Isung","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"C818","DOI":"10.1152\/ajpcell.00580.2019","article-title":"The Kynurenine Connection: How Exercise Shifts Muscle Tryptophan Metabolism and Affects Energy Homeostasis, the Immune System, and the Brain","volume":"318","author":"Martin","year":"2020","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1113\/JP284142","article-title":"Exercise and Aging Impact Kynurenine\/Tryptophan Pathway and Acylcarnitine Metabolite Pools in Skeletal Muscle of Older Adults","volume":"601","author":"Hinkley","year":"2023","journal-title":"J. Physiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e70041","DOI":"10.1111\/apha.70041","article-title":"Exercise Training Restores Longevity-Associated Tryptophan Metabolite 3-Hydroxyanthranilic Acid Levels in Middle-Aged Adults","volume":"241","author":"Joisten","year":"2025","journal-title":"Acta Physiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbi.2015.12.020","article-title":"Mouse Chronic Social Stress Increases Blood and Brain Kynurenine Pathway Activity and Fear Behaviour: Both Effects Are Reversed by Inhibition of Indoleamine 2,3-Dioxygenase","volume":"54","author":"Fuertig","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neubiorev.2020.08.010","article-title":"Effect of Immune Activation on the Kynurenine Pathway and Depression Symptoms\u2014A Systematic Review and Meta-Analysis","volume":"118","author":"Hunt","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Luo, Y., Jiang, N., Zhang, Y., Zhao, Y., Chen, F., Li, X., Qiang, M., Zeng, G., He, Q., and Liu, X. (2025). Chronic Unpredictable Mild Stress Induces Anxiety-like Behavior in Female C57BL\/6N Mice, Accompanied by Alterations in Inflammation and the Kynurenine Pathway of Tryptophan Metabolism. Front. Neurosci., 19.","DOI":"10.3389\/fnins.2025.1556744"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Myint, K., Jacobs, K., Myint, A.-M., Lam, S.K., Lim, Y.A.-L., Boey, C.C.-M., Hoe, S.Z., and Guillemin, G.J. (2021). Psychological Stresses in Children Trigger Cytokine- and Kynurenine Metabolite-Mediated Abdominal Pain and Proinflammatory Changes. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.702301"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Ilavsk\u00e1, L., Morvov\u00e1, M., Paduchov\u00e1, Z., Muchov\u00e1, J., Garaiova, I., \u010eura\u010dkov\u00e1, Z., \u0160ikurov\u00e1, L., and Trebatick\u00e1, J. (2024). The Kynurenine and Serotonin Pathway, Neopterin and Biopterin in Depressed Children and Adolescents: An Impact of Omega-3 Fatty Acids, and Association with Markers Related to Depressive Disorder. A Randomized, Blinded, Prospective Study. Front. Psychiatry, 15.","DOI":"10.3389\/fpsyt.2024.1347178"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1021\/acs.jmedchem.5b00461","article-title":"Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway","volume":"58","author":"Dounay","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"104753","DOI":"10.1016\/j.jbc.2023.104753","article-title":"Indoleamine Dioxygenase and Tryptophan Dioxygenase Activities Are Regulated through Control of Cell Heme Allocation by Nitric Oxide","volume":"299","author":"Biswas","year":"2023","journal-title":"J. Biol. Chem."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Meireson, A., Devos, M., and Brochez, L. (2020). IDO Expression in Cancer: Different Compartment, Different Functionality?. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.531491"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/s41467-017-01725-8","article-title":"Structural Insights into Substrate and Inhibitor Binding Sites in Human Indoleamine 2,3-Dioxygenase 1","volume":"8","author":"Pham","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.1158\/0008-5472.CAN-07-1872","article-title":"Novel Tryptophan Catabolic Enzyme IDO2 Is the Preferred Biochemical Target of the Antitumor Indoleamine 2,3-Dioxygenase Inhibitory Compound d-1-Methyl-Tryptophan","volume":"67","author":"Metz","year":"2007","journal-title":"Cancer Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.drudis.2014.11.007","article-title":"Targeting Key Dioxygenases in Tryptophan\u2013Kynurenine Metabolism for Immunomodulation and Cancer Chemotherapy","volume":"20","author":"Austin","year":"2015","journal-title":"Drug Discov. Today"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0028-3908(94)00147-K","article-title":"The Effects of an Inhibitor of Tryptophan 2,3-Dioxygenase and a Combined Inhibitor of Tryptophan 2,3-Dioxygenase and 5-HT Reuptake in the Rat","volume":"34","author":"Salter","year":"1995","journal-title":"Neuropharmacology"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Oweira, H., Lahdou, I., Mehrle, S., Khajeh, E., Nikbakhsh, R., Ghamarnejad, O., Terness, P., Rei\u00dffelder, C., Sadeghi, M., and Ramouz, A. (2022). Kynurenine Is the Main Metabolite of Tryptophan Degradation by Tryptophan 2,3-Dioxygenase in HepG2 Tumor Cells. J. Clin. Med., 11.","DOI":"10.3390\/jcm11164794"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1021\/jm2006782","article-title":"Tryptophan 2,3-Dioxygenase (TDO) Inhibitors. 3-(2-(Pyridyl)Ethenyl)Indoles as Potential Anticancer Immunomodulators","volume":"54","author":"Larrieu","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_131","unstructured":"Waring, M.J. (2018). Inhibitors of the Kynurenine Pathway. Cancer II, Springer International Publishing."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Panfili, E., Mondanelli, G., Orabona, C., Gargaro, M., Volpi, C., Belladonna, M.L., Rossini, S., Suvieri, C., and Pallotta, M.T. (2023). The Catalytic Inhibitor Epacadostat Can Affect the Non-Enzymatic Function of IDO1. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1134551"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Komiya, T., and Huang, C.H. (2018). Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers. Front. Oncol., 8.","DOI":"10.3389\/fonc.2018.00423"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Xue, Z., Yang, Y., Li, B., Li, W., Chen, J., and Pan, Y. (2022). IDO Level Increase in Kynurenine Pathway Contributes to the Development of Alzheimer\u2019s Disease, Association for Computing Machinery.","DOI":"10.1145\/3570773.3570797"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00262-012-1265-x","article-title":"Effects of 1-Methyltryptophan Stereoisomers on IDO2 Enzyme Activity and IDO2-Mediated Arrest of Human T Cell Proliferation","volume":"61","author":"Qian","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuro.2021.03.009","article-title":"IDO-1 Inhibition Protects against Neuroinflammation, Oxidative Stress and Mitochondrial Dysfunction in 6-OHDA Induced Murine Model of Parkinson\u2019s Disease","volume":"84","author":"Sodhi","year":"2021","journal-title":"NeuroToxicology"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"8136","DOI":"10.18632\/oncotarget.2357","article-title":"A First in Man Phase I Trial of the Oral Immunomodulator, Indoximod, Combined with Docetaxel in Patients with Metastatic Solid Tumors","volume":"5","author":"Soliman","year":"2014","journal-title":"Oncotarget"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/neuonc\/noad174","article-title":"Indoximod-Based Chemo-Immunotherapy for Pediatric Brain Tumors: A First-in-Children Phase I Trial","volume":"26","author":"Johnson","year":"2024","journal-title":"Neuro-Oncology"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"127963","DOI":"10.1016\/j.bmcl.2021.127963","article-title":"Discovery of 5-(N-Hydroxycarbamimidoyl) Benzofuran Derivatives as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors","volume":"40","author":"Jung","year":"2021","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1158\/0008-5472.CAN-17-2285","article-title":"Discovery of IDO1 Inhibitors: From Bench to Bedside","volume":"77","author":"Prendergast","year":"2017","journal-title":"Cancer Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"127738","DOI":"10.1016\/j.bmcl.2020.127738","article-title":"Discovery of Highly Potent Heme-Displacing IDO1 Inhibitors Based on a Spirofused Bicyclic Scaffold","volume":"33","author":"Kinzel","year":"2021","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"127744","DOI":"10.1016\/j.bmcl.2020.127744","article-title":"Discovery and Optimization of Substituted Oxalamides as Novel Heme-Displacing IDO1 Inhibitors","volume":"33","author":"Steeneck","year":"2021","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ejmech.2018.11.010","article-title":"Diaryl Hydroxylamines as Pan or Dual Inhibitors of Indoleamine 2,3-Dioxygenase-1, Indoleamine 2,3-Dioxygenase-2 and Tryptophan Dioxygenase","volume":"162","author":"Winters","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1002\/cmdc.202100107","article-title":"A Series of 2-((1-Phenyl-1H-Imidazol-5-Yl)Methyl)-1H-Indoles as Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors","volume":"16","author":"Zheng","year":"2021","journal-title":"ChemMedChem"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"P195","DOI":"10.1186\/2051-1426-2-S3-P195","article-title":"Preclinical Assessment of a Novel Small Molecule Inhibitor of Indoleamine 2,3-Dioxygenase 1 (IDO1)","volume":"2","author":"Driessens","year":"2014","journal-title":"J. Immunother. Cancer"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.bmc.2012.12.028","article-title":"Synthesis and Biological Evaluation of Novel Tryptoline Derivatives as Indoleamine 2,3-Dioxygenase (IDO) Inhibitors","volume":"21","author":"Tanaka","year":"2013","journal-title":"Bioorganic Med. Chem."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"117597","DOI":"10.1016\/j.ejmech.2025.117597","article-title":"Proof of Concept Study for Developing 1-Thienyl-\u03b2-Carboline Derivatives as IDO1 and TDO Dual Inhibitors to Treat Parkinson\u2019s Disease Complicating Depression","volume":"291","author":"Chen","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"112703","DOI":"10.1016\/j.ejmech.2020.112703","article-title":"Discovery and Structure-Activity Relationship Studies of 1-Aryl-1H-Naphtho [2,3-d][1,2,3]Triazole-4,9-Dione Derivatives as Potent Dual Inhibitors of Indoleamine 2,3-Dioxygenase 1 (IDO1) and Trytophan 2,3-Dioxygenase (TDO)","volume":"207","author":"Pan","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"111985","DOI":"10.1016\/j.ejmech.2019.111985","article-title":"Design, Synthesis and Biological Evaluation of Indole-2-Carboxylic Acid Derivatives as IDO1\/TDO Dual Inhibitors","volume":"188","author":"Cui","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"116852","DOI":"10.1016\/j.ejmech.2024.116852","article-title":"Discovery, Synthesis and Biological Evaluation of Novel Isoquinoline Derivatives as Potent Indoleamine 2, 3-Dioxygenase 1 and Tryptophan 2, 3-Dioxygenase Dual Inhibitors","volume":"279","author":"Lin","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"113244","DOI":"10.1016\/j.phytochem.2022.113244","article-title":"Eleven Undescribed Alkaloids from the Rhizomes of Sinomenium acutum and Their IDO1 and TDO Inhibitory Activities","volume":"200","author":"Bi","year":"2022","journal-title":"Phytochemistry"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"113794","DOI":"10.1016\/j.phytochem.2023.113794","article-title":"Discovery and Biological Evaluation of a New Type of Dual Inhibitors of Indoleamine 2,3-Dioxygenase 1 and Tryptophan 2,3-Dioxygenase from Ethnomedicinal Plant Dactylicapnos scandens","volume":"214","author":"Bao","year":"2023","journal-title":"Phytochemistry"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"127910","DOI":"10.1016\/j.bmcl.2021.127910","article-title":"IDO1 and TDO Inhibitory Evaluation of Analogues of the Marine Pyrroloiminoquinone Alkaloids: Wakayin and Tsitsikammamines","volume":"40","author":"Levy","year":"2021","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"114294","DOI":"10.1016\/j.ejmech.2022.114294","article-title":"Discovery and Biological Evaluation of Tanshinone Derivatives as Potent Dual Inhibitors of Indoleamine 2, 3-Dioxygenase 1 and Tryptophan 2, 3-Dioxygenase","volume":"235","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.drudis.2015.11.001","article-title":"Kynurenine-3-Monooxygenase: A Review of Structure, Mechanism, and Inhibitors","volume":"21","author":"Smith","year":"2016","journal-title":"Drug Discov. Today"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1021\/jm501350y","article-title":"Development of a Series of Aryl Pyrimidine Kynurenine Monooxygenase Inhibitors as Potential Therapeutic Agents for the Treatment of Huntington\u2019s Disease","volume":"58","author":"Prime","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"36554","DOI":"10.1074\/jbc.M113.503813","article-title":"Targeted Deletion of Kynurenine 3-Monooxygenase in Mice","volume":"288","author":"Giorgini","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature12039","article-title":"Structural Basis of Kynurenine 3-Monooxygenase Inhibition","volume":"496","author":"Amaral","year":"2013","journal-title":"Nature"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0306-4522(00)00504-2","article-title":"Kynurenine 3-Mono-Oxygenase Activity and Neurotoxic Kynurenine Metabolites Increase in the Spinal Cord of Rats with Experimental Allergic Encephalomyelitis","volume":"102","author":"Chiarugi","year":"2001","journal-title":"Neuroscience"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"18270","DOI":"10.3390\/ijms160818270","article-title":"Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System","volume":"16","author":"Rajda","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/npp.2017.21","article-title":"Attenuating Nicotine Reinforcement and Relapse by Enhancing Endogenous Brain Levels of Kynurenic Acid in Rats and Squirrel Monkeys","volume":"42","author":"Secci","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1111\/bph.15825","article-title":"Influx of Kynurenine into the Brain Is Involved in the Reduction of Ethanol Consumption Induced by Ro\u200961-8048 after Chronic Intermittent Ethanol in Mice","volume":"179","author":"Vidal","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jnr.24489","article-title":"Modification of Kynurenine Pathway via Inhibition of Kynurenine Hydroxylase Attenuates Surgical Brain Injury Complications in a Male Rat Model","volume":"98","author":"Zakhary","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1046\/j.1471-4159.2002.01090.x","article-title":"Kynurenine 3-Mono-Oxygenase Inhibitors Attenuate Post-Ischemic Neuronal Death in Organotypic Hippocampal Slice Cultures","volume":"82","author":"Carpenedo","year":"2002","journal-title":"J. Neurochem."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration","volume":"145","author":"Zwilling","year":"2011","journal-title":"Cell"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1002\/jcp.30876","article-title":"Kynurenine-3-Monooxygenase (KMO): From Its Biological Functions to Therapeutic Effect in Diseases Progression","volume":"237","author":"Chen","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"127753","DOI":"10.1016\/j.bmcl.2020.127753","article-title":"N-(6-Phenylpyridazin-3-Yl)Benzenesulfonamides as Highly Potent, Brain-Permeable, and Orally Active Kynurenine Monooxygenase Inhibitors","volume":"33","author":"Kimura","year":"2021","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"128115","DOI":"10.1016\/j.bmcl.2021.128115","article-title":"Discovery of N-(6-(5-Fluoro-2-(Piperidin-1-Yl)Phenyl)Pyridazin-3-Yl)-1-(Tetrahydro-2H-Pyran-4-Yl)Methanesulfonamide as a Brain-Permeable and Metabolically Stable Kynurenine Monooxygenase Inhibitor","volume":"44","author":"Tsuboi","year":"2021","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.bmcl.2017.02.080","article-title":"Substrate and Inhibitor Specificity of Kynurenine Monooxygenase from Cytophaga hutchinsonii","volume":"27","author":"Phillips","year":"2017","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Puopolo, T., Chang, T., Liu, C., Li, H., Liu, X., Wu, X., Ma, H., and Seeram, N.P. (2022). Gram-Scale Preparation of Cannflavin A from Hemp (Cannabis sativa L.) and Its Inhibitory Effect on Tryptophan Catabolism Enzyme Kynurenine-3-Monooxygenase. Biology, 11.","DOI":"10.3390\/biology11101416"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"e30287","DOI":"10.1016\/j.heliyon.2024.e30287","article-title":"Identification of Potent Inhibitors of Kynurenine-3-Monooxygenase from Natural Products: In Silico and In Vitro Approaches","volume":"10","author":"Rebai","year":"2024","journal-title":"Heliyon"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"107701","DOI":"10.1016\/j.jmgm.2020.107701","article-title":"In Silico Methods Predict New Blood-Brain Barrier Permeable Structure for the Inhibition of Kynurenine 3-Monooxygenase","volume":"100","year":"2020","journal-title":"J. Mol. Graph. Model."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"115258","DOI":"10.1016\/j.ejmech.2023.115258","article-title":"Therapeutic Potential of Targeting Kynurenine Pathway in Neurodegenerative Diseases","volume":"251","author":"Shen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00702-006-0562-y","article-title":"Kynurenic Acid Leads, Dopamine Follows: A New Case of Volume Transmission in the Brain?","volume":"114","author":"Wu","year":"2007","journal-title":"J. Neural. Transm."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bcp.2012.07.030","article-title":"Kynurenic Acid Inhibits Glutamatergic Transmission to CA1 Pyramidal Neurons via A7 nAChR-Dependent and -Independent Mechanisms","volume":"84","author":"Banerjee","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Nematollahi, A., Sun, G., Jayawickrama, G.S., and Church, W.B. (2016). Kynurenine Aminotransferase Isozyme Inhibitors: A Review. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17060946"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1074\/jbc.M707925200","article-title":"Crystal Structure of Human Kynurenine Aminotransferase II, a Drug Target for the Treatment of Schizophrenia","volume":"283","author":"Rossi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_178","unstructured":"Blanco Ayala, T., Lugo Huitr\u00f3n, R., Carmona Aparicio, L., Ram\u00edrez Ortega, D., Gonz\u00e1lez Esquivel, D., Pedraza Chaverr\u00ed, J., P\u00e9rez de la Cruz, G., R\u00edos, C., Schwarcz, R., and P\u00e9rez de la Cruz, V. (2015). Alternative Kynurenic Acid Synthesis Routes Studied in the Rat Cerebellum. Front. Cell. Neurosci., 9."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1016\/S0021-9258(17)33156-3","article-title":"Reactivity of the Phosphopyridoxal Groups of Cystathionase","volume":"251","author":"Beeler","year":"1976","journal-title":"J. Biol. Chem."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.1471-4159.1991.tb08258.x","article-title":"Aminooxyacetic Acid Results in Excitotoxin Lesions by a Novel Indirect Mechanism","volume":"57","author":"Beal","year":"1991","journal-title":"J. Neurochem."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/cmdc.200500095","article-title":"Modulators of the Kynurenine Pathway of Tryptophan Metabolism: Synthesis and Preliminary Biological Evaluation of (S)-4-(Ethylsulfonyl)Benzoylalanine, a Potent and Selective Kynurenine Aminotransferase II (KAT II) Inhibitor","volume":"1","author":"Pellicciari","year":"2006","journal-title":"ChemMedChem"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/cmdc.200800109","article-title":"Sequence Variants in Kynurenine Aminotransferase II (KAT II) Orthologs Determine Different Potencies of the Inhibitor S -ESBA","volume":"3","author":"Carotti","year":"2008","journal-title":"ChemMedChem"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuroscience.2008.11.055","article-title":"Specific Inhibition of Kynurenate Synthesis Enhances Extracellular Dopamine Levels in the Rodent Striatum","volume":"159","author":"Amori","year":"2009","journal-title":"Neuroscience"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: When physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1093\/schbul\/sbt157","article-title":"Targeting Kynurenine Aminotransferase II in Psychiatric Diseases: Promising Effects of an Orally Active Enzyme Inhibitor","volume":"40","author":"Wu","year":"2014","journal-title":"Schizophr. Bull."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.1021\/jm100464k","article-title":"Crystal Structure-Based Selective Targeting of the Pyridoxal 5\u2032-Phosphate Dependent Enzyme Kynurenine Aminotransferase II for Cognitive Enhancement","volume":"53","author":"Rossi","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1021\/ml200204m","article-title":"Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia","volume":"3","author":"Dounay","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuroscience.2020.07.049","article-title":"N-Acetylcysteine Inhibits Kynurenine Aminotransferase II","volume":"444","author":"Sathyasaikumar","year":"2020","journal-title":"Neuroscience"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-2999(99)00196-X","article-title":"Tryptophan Metabolism and Brain Function: Focus on Kynurenine and Other Indole Metabolites","volume":"375","author":"Moroni","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1178646917691938","DOI":"10.1177\/1178646917691938","article-title":"Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects","volume":"10","author":"Badawy","year":"2017","journal-title":"Int. J. Tryptophan Res."},{"key":"ref_191","unstructured":"Filippini, G.A., Costa, C.V.L., and Bertazzo, A. (1996). Kynurenine Hydroxylase and Kynureninase Inhibitors as Tools to Study the Role of Kynurenine Metabolites in the Central Nervous System. Recent Advances in Tryptophan Research: Tryptophan and Serotonin Pathways, Springer."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1021\/jm00031a015","article-title":"Modulation of the Kynurenine Pathway in Search for New Neuroprotective Agents.Synthesis and Preliminary Evaluation of (m-Nitrobenzoyl)Alanine, a Potent Inhibitor of Kynurenine-3-Hydroxylase","volume":"37","author":"Pellicciari","year":"1994","journal-title":"J. Med. Chem."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.bjp.0701834","article-title":"Modulation of Striatal Quinolinate Neurotoxicity by Elevation of Endogenous Brain Kynurenic Acid","volume":"124","author":"Harris","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0306-4522(94)90227-5","article-title":"Inhibitors of Kynurenine Hydroxylase and Kynureninase Increase Cerebral Formation of Kynurenate and Have Sedative and Anticonvulsant Activities","volume":"61","author":"Carpenedo","year":"1994","journal-title":"Neuroscience"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0021-9258(18)81257-1","article-title":"Studies on the Biological Activity of Nicotinylalanine, an Analogue of Kynurenine","volume":"238","author":"Decker","year":"1963","journal-title":"J. Biol. Chem."},{"key":"ref_196","unstructured":"(2025, August 31). Dementia. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"eabm6131","DOI":"10.1126\/science.abm6131","article-title":"Restoring Hippocampal Glucose Metabolism Rescues Cognition across Alzheimer\u2019s Disease Pathologies","volume":"385","author":"Minhas","year":"2024","journal-title":"Science"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"9484217","DOI":"10.1155\/2022\/9484217","article-title":"Kynurenine Pathway Metabolites as Biomarkers in Alzheimer\u2019s Disease","volume":"2022","author":"Liang","year":"2022","journal-title":"Dis. Markers"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/fsn3.1418","article-title":"Kynurenine-3-Monooxygenase: A New Direction for the Treatment in Different Diseases","volume":"8","author":"Lu","year":"2020","journal-title":"Food Sci. Nutr."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s Disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ntt.2010.10.002","article-title":"Protective Effect of L-Kynurenine and Probenecid on 6-Hydroxydopamine-Induced Striatal Toxicity in Rats: Implications of Modulating Kynurenate as a Protective Strategy","volume":"33","year":"2011","journal-title":"Neurotoxicology Teratol."},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Bytowska, Z.K., Korewo-Labelle, D., Kowalski, K., Libionka, W., Przew\u0142\u00f3cka, K., Kloc, W., and Kaczor, J.J. (2023). Impact of 12 Weeks of Vitamin D3 Administration in Parkinson\u2019s Patients with Deep Brain Stimulation on Kynurenine Pathway and Inflammatory Status. Nutrients, 15.","DOI":"10.3390\/nu15173839"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s42003-019-0520-5","article-title":"A Brain-Permeable Inhibitor of the Neurodegenerative Disease Target Kynurenine 3-Monooxygenase Prevents Accumulation of Neurotoxic Metabolites","volume":"2","author":"Zhang","year":"2019","journal-title":"Commun. Biol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/jnc.15360","article-title":"Kynurenine Pathway Metabolites in Cerebrospinal Fluid and Blood as Potential Biomarkers in Huntington\u2019s Disease","volume":"158","author":"Rodrigues","year":"2021","journal-title":"J. Neurochem."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cub.2011.04.028","article-title":"The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington\u2019s Disease","volume":"21","author":"Campesan","year":"2011","journal-title":"Curr. Biol."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Carrillo-Mora, P., Landa-Sol\u00eds, C., Valle-Garcia, D., Luna-Angulo, A., Avil\u00e9s-Arnaut, H., Robles-Ba\u00f1uelos, B., S\u00e1nchez-Chapul, L., and Rangel-L\u00f3pez, E. (2024). Kynurenines and Inflammation: A Remarkable Axis for Multiple Sclerosis Treatment. Pharmaceuticals, 17.","DOI":"10.3390\/ph17080983"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12974-020-01844-y","article-title":"Kynurenine Pathway Modulation Reverses the Experimental Autoimmune Encephalomyelitis Mouse Disease Progression","volume":"17","author":"Sundaram","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"149415","DOI":"10.1016\/j.brainres.2024.149415","article-title":"Kynurenine Pathway Dysregulation as a Mechanistic Link between Cognitive Impairment and Brain Damage: Implications for Multiple Sclerosis","volume":"1853","author":"Kupjetz","year":"2025","journal-title":"Brain Res."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"177686","DOI":"10.1016\/j.ejphar.2025.177686","article-title":"Edaravone Protects against Cuprizone-Induced Demyelination in Rats by Modulating TNF-\u03b1\/NF-\u0138B\/NLRP3 Signaling and the Kynurenine Pathway","volume":"999","author":"Mahmoud","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"ref_210","unstructured":"(2025, September 28). Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KNS366. Available online: https:\/\/www.isrctn.com\/ISRCTN10496020."},{"key":"ref_211","unstructured":"Kynexis, B.V. (2025, November 13). A First in Human Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Phar-Macokinetics of Single and Multiple Ascending Oral Doses of KYN-5356 in Adult, Healthy Subjects, Available online: https:\/\/clinicaltrials.gov\/study\/NCT07191483?term=KYN-5356&rank=1."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"894","DOI":"10.4049\/jimmunol.179.2.894","article-title":"Blockade of IDO Inhibits Nasal Tolerance Induction1","volume":"179","author":"Samsom","year":"2007","journal-title":"J. Immunol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.4049\/jimmunol.0804328","article-title":"The Immunoregulatory Enzyme IDO Paradoxically Drives B Cell-Mediated Autoimmunity","volume":"182","author":"Scott","year":"2009","journal-title":"J. Immunol."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"T\u00f6r\u00f6k, N., Tanaka, M., and V\u00e9csei, L. (2020). Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway. Int. J. Mol. Sci., 21.","DOI":"10.20944\/preprints202011.0396.v1"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1002\/alz.13162","article-title":"Higher Concentrations of Kynurenic Acid in CSF Are Associated with the Slower Clinical Progression of Alzheimer\u2019s Disease","volume":"19","author":"Knapskog","year":"2023","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00406-012-0384-x","article-title":"Increased 3-Hydroxykynurenine Serum Concentrations Differentiate Alzheimer\u2019s Disease Patients from Controls","volume":"263","author":"Schwarz","year":"2013","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"100270","DOI":"10.1016\/j.ensci.2020.100270","article-title":"Kynurenine Pathway in Parkinson\u2019s Disease\u2014An Update","volume":"21","author":"Venkatesan","year":"2020","journal-title":"eNeurologicalSci"},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Tanaka, M., Szatm\u00e1ri, I., and V\u00e9csei, L. (2025). Quinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design. Pharmaceuticals, 18.","DOI":"10.20944\/preprints202503.2399.v1"},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Mithaiwala, M.N., Santana-Coelho, D., Porter, G.A., and O\u2019Connor, J.C. (2021). Neuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications. Cells, 10.","DOI":"10.3390\/cells10061548"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jnc.14843","article-title":"Age- and Disease-specific Changes of the Kynurenine Pathway in Parkinson\u2019s and Alzheimer\u2019s Disease","volume":"151","author":"Sorgdrager","year":"2019","journal-title":"J. Neurochem."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","article-title":"The Kynurenine Pathway and the Brain: Challenges, Controversies and Promises","volume":"112","author":"Schwarcz","year":"2017","journal-title":"Neuropharmacology"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/2\/266\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T09:10:20Z","timestamp":1770196220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/2\/266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":221,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["life16020266"],"URL":"https:\/\/doi.org\/10.3390\/life16020266","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]}}}